Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMDC-USR for Male Stress Urinary Incontinence Post-Prostate Surgery
NCT02291432Phase 2Completed
- Sponsor
- Cook MyoSite
- Start
- Feb 2015
- Primary completion
- Jun 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AMDC-USR in stress urinary incontinence (SUI), sponsored by Cook MyoSite. Primary endpoints: Rate of Product-related, Biopsy Procedure-related, and Injection Procedure-related Adverse Events at 24 months and Volume of Post-void Residual Urine at 12 months. Started Feb 2015; status: completed.
02
Drugs
AMDC-USR
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT02291432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291432.